Skip Nav

Contact Us

Chondrosarcoma CS Foundation, Inc.

Thank you for your interest in our company. Complete the form below to send us an email, or simply give us a call. We're looking forward to working with you.

  • 301-352-3042

    Thank You!

    Your message has been sent.

    Oops, message not sent.

    Please make sure fields are complete.

    Uncategorized Posts

    Article on Targeted Cancer Therapies

    May 26th, 2021
    Targeted Cancer Therapies ON THIS PAGE What are targeted cancer therapies? How are targets for targeted cancer therapies identified? How are targeted therapies developed? What types of targeted therapies are available? …

    Read Article

    Empowering Patients to Speak Up for Your Health

    May 25th, 2021
    Check out the video hosted by Memorial Sloan Kettering entitled: Empowering Patients: Speak Up for Your Health. The link is listed below as well as the transcript. The Empowered Patient: Speak Up for Your Health | Memorial Sloan Kettering Cancer…

    Read Article

    Inhibrx Announces Positive Interim Results from the Phase 1 Trial of INBRX-109 in Chondrosarcoma Patients

    May 16th, 2021
    SAN DIEGO, Nov. 11, 2020 /PRNewswire/ –InhibRx, Inc. (Nasdaq: INBX), a biotechnology company with four clinical programs in development, announced updated interim results today from a Phase 1 clinical trial evaluating the efficacy and safety of…

    Read Article

    Chondrosarcoma (CS) Foundation Celebrates It First Anniversary

    May 8th, 2021

    This coming Friday will be the Chondrosarcoma Foundation’s first anniversary. Last year, on May 14, 2020 during the beginning of the pandemic, we launched the Chondrosarcoma Foundation by bringing CS Foundation web site on-line. My…

    Read Article

    Inbrx-109 Phase 1 Trial Shows Positive Interim Results in Patients with Chondrosarcoma

    May 7th, 2021
    November 13, 2020 Dylann Cohn-Emery Treatment with the investigation agent INBRX-109 induced responses and decreased the tumor burden in a cohort of patients with chondrosarcoma, according to interim efficacy and safety findings a phase 1 trial in…

    Read Article

    INBRX-!09 on the Fast Track for Metastatic Conventional Chondrosarcoma Patients


    Inhibrx Granted Fast Track Designation for INBRX-109 for the Treatment of Unresectable or Metastatic Conventional Chondrosarcoma Patients Registration-enabling study expected to begin dosing in the second or third quarter of this year

    Read Article

    Is the IDH Mutation a Good Target for Chondrosarcoma Treatment?

    April 30th, 2021
    Elena Cojocaru, Christopher Wilding, Bodil Engelman, Paul Huang & Robin L. Jones Current Molecular Biology Reports volume 6, pages1–9(2020)Cite this article Is the IDH Mutation a Good Target for Chondrosarcoma Treatment? |…

    Read Article

    Multigenerational and Transgenerational Effects of Dioxins As the Cause of Cancer


    Abstract Dioxins are ubiquitous and persistent environmental contaminants whose background levels are still reason for concern. There is mounting evidence from both epidemiological and experimental studies that paternal exposure to the most potent…

    Read Article

    In Memory of Sebastian


    Sebastien passed away July 14, 2020 from dedifferentiated chondrosarcoma. This narrative was written and submitted by his sister Stephanie Desjardins. In April 2019, my brother was diagnosed with a chondrosarcoma of chest wall on the right side…

    Read Article

    Memorial Sloan Kettering Information Session: Empowering Patients: Speak Up For Your Health

    April 29th, 2021
    Empowering Patients: Speak Up For Your Health Tuesday, May 11, 2021 at 12:00 PM ET Please consider registering to a special information session where our panel of experts will discuss the importance of advocating for patient care and treatment….

    Read Article

    Contact Information


    If you would like to learn more about CS Foundation or if you would like to learn more about the resources we provide to patients, families, caregivers, and physicians, please contact us by phone or send us a message.

    **A Registered 501c3 Non-Profit Charity Organization. All donations are tax-deductible.**

    Send a Message